Triple therapy for chronic hepatitis C: Practical Aspects

Abstract

The paper considers the practical aspects of antiviral therapy with protease inhibitors, a new group of antiviral agents, by using the clinical cases of treatment in patients with chronic hepatitis C as an example. It gives the general points of triple therapy, including indications for its use in previously untreated and unresponsive patients, and discusses in detail possible adverse events and ways of their prevention and correction.

Keywords

• chronic hepatitis c
• antiviral therapy
• protease inhibitors
• telaprevir
• boceprevir
• adverse events